Eli Lilly & Company: Currently acting for Eli Lilly in connection with patent infringement and revocation proceedings for its gemcitabine hydrochloride molecule which forms the basis of its successful anti-cancer treatment GEMZAR.
Confidential client: Currently acting for the local subsidiary of a major Chinese corporation in determining trade secret and copyright claims brought by a competitor in relation to grinding mills.
AstraZeneca Pty Ltd: Advised AstraZeneca on the appropriate patents to be referenced under the new Pharmaceutical Benefits Scheme Reforms.
Singtel Optus: Successfully acted for Optus in the High Court dispute with Telstra and the ACCC concerning the constitutional basis of the ACCC's power to regulate telecommunications in Australia.
Redberry Enterprises Pty Ltd: Successfully acted for Redberry Enterprises Pty Ltd in the first Australian court decision to consider in detail the new infringement test under the Designs Act 2003 (Cth).
Sandoz (formerly Biochemie): Successfully represented Sandoz in proceedings concerning formulation patents for the gastric reflux molecule omeprazole.
AAPT: Acted for AAPT Limited in relation to telecommunications claims concerning Telstra's billing platforms including trade practices and misuse of market power claims.
Asea Brown Boveri: Advising on a number of mechanical patent matters concerning machinery and components in relation to air conditioning systems and ducting for power stations.
Ludowici Limited: Advised on patent and copyright infringement issues concerning mineral processing equipment.
Go Talk Australia Pty Ltd: Acted in a patent infringement action brought in the Federal Court of Australia against Answer Pre Paid Pty Ltd and Alpha Telecom Pty Ltd for infringement of an Innovation Patent directed to a real time pre-paid call access system.
